Pediatric Care Concerns Amid Closure of Mass General Brigham’s PANS/PANDAS Program
Mass General Brigham (MGB) is facing significant backlash from families after the announcement of its plans to shut down the PANS/PANDAS program, which serves children with specific medical and psychiatric conditions. The announcement, coming less than three months after the hospital first communicated its intentions, has left many patients and their families in uncertainty regarding their future treatment options.
Initial Closure Announcement
In January, MGB informed families of their decision to close the PANS/PANDAS program offered through Mass General Brigham for Children. Following the closure notice, hospital officials indicated that patients would still have the opportunity to continue their care within the MGB system. The aim was to ensure that continuity of treatment would still be preserved.
Confusion Over Doctor’s Departure
Recent communications from the hospital concerning Dr. Kyle Williams, one of the few doctors specializing in PANS/PANDAS treatment at MGB, added to the confusion. In response to an erroneous message sent to families, MGB clarified that Dr. Williams would be leaving at the end of the year, contradicting the initial assurance about maintaining care continuity. The hospital expressed regret for any misunderstanding resulting from their previous communications.
Community Responses
Parents and advocates have voiced their concerns, emphasizing the need for a clear transition plan. Jennifer Vitelli, executive director of the Look. Foundation, criticized the hospital’s recent messaging as “incredibly confusing,” stating that families are merely provided with a list of alternative providers without the necessary details on referrals or appointments.
The Importance of Specialized Care
The PANS/PANDAS program was one of the rare initiatives nationwide addressing these complex conditions, which combine both medical and psychiatric aspects. With its closure, parents worry that they might struggle to find alternative specialized care. For instance, while the hospital suggested considering distant clinics or specialists, many families expressed that these options could be impractical due to travel or financial constraints.
Continuity of Care Concerns
The recent notice from MGB included alternative names for care, including Dr. Yujuan (Julia) Zhang, a pediatric rheumatologist with a long waiting list. However, local advocates have criticized this approach, remarking that referrals should be more specific given the urgent need for continued treatment.
As highlighted by Jessica Purcell, a mother of two children receiving care at MGB, Dr. Williams played a crucial role in managing her children’s treatment, indicating the importance of continuity and trust established in care routines.
Challenges in Securing Treatment
Families have long faced difficulties in securing timely and effective care for PANS/PANDAS. Treatments, which can encompass antibiotics, anti-inflammatories, and behavioral therapies as well as more severe interventions like intravenous immunoglobulin (IVIG), require a coordinated approach that is currently in jeopardy due to the program’s closure.
Looking Ahead
The American Academy of Pediatrics (AAP) has recognized PANS as a “likely valid diagnosis,” heralding an increase in awareness while stressing the need for further research and prudent treatment approaches.
Despite reassurances from MGB about the availability of other specialists in the child psychiatry department, concerns remain regarding the accessibility of vital treatments, a necessity for many families affected. As the timeline for the program’s closure nears, the urgency for clear strategies and accessible care has never been more apparent.
Dr. Williams’ departure only exacerbates fears among parents about ensuring their children receive comprehensive treatment for both the medical and psychiatric symptoms associated with PANS/PANDAS.
As this situation continues to evolve, families and advocacy groups demand transparency and a well-defined care plan to minimize disruptions in treatment for their children.
For more information, please feel free to contact Allyson Chiu at allyson.chiu@globe.com.
